Emergent BioSolutions
EBS
#7548
Rank
โ‚น40.70 B
Marketcap
โ‚น789.00
Share price
1.12%
Change (1 day)
32.81%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚น40.70 Billion

As of May 2026 Emergent BioSolutions has a market cap of โ‚น40.70 Billion. This makes Emergent BioSolutions the world's 7548th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น40.70 B-31.62%
2025โ‚น59.53 B54.86%
2024โ‚น38.44 B270.83%
2023โ‚น10.36 B-78.74%
2022โ‚น48.75 B-71.99%
2021โ‚น174.06 B-49.88%
2020โ‚น347.29 B74.61%
2019โ‚น198.90 B-6.28%
2018โ‚น212.22 B43.35%
2017โ‚น148.04 B63.81%
2016โ‚น90.37 B-13.74%
2015โ‚น104.77 B61%
2014โ‚น65.07 B25.11%
2013โ‚น52.01 B65.13%
2012โ‚น31.50 B-1.64%
2011โ‚น32.02 B-12.98%
2010โ‚น36.80 B89.31%
2009โ‚น19.44 B-48.23%
2008โ‚น37.55 B535.61%
2007โ‚น5.90 B-56.69%
2006โ‚น13.64 B

End of Day market cap according to different sources

On May 20th, 2026 the market cap of Emergent BioSolutions was reported to be:

โ‚น40.68 Billion
by Nasdaq info icon info icon
โ‚น40.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.229 T 34,854.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น27.018 T 66,269.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น9.864 T 24,132.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
โ‚น0.55 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น31.17 B-23.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น234.80 B 476.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.868 T 9,403.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel